Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition.
Lung transplantation is a recognised treatment for patients with end stage pulmonary disease. Transplant recipients receive life-long administration of immunosuppressive drugs that target T cell mediated graft rejection. However little is known of the impact on NK cells, which have the potential to...
Main Authors: | Aislin C Meehan, Nicole A Mifsud, Thi H O Nguyen, Bronwyn J Levvey, Greg I Snell, Tom C Kotsimbos, Glen P Westall |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3605368?pdf=render |
Similar Items
-
Cross-reactive anti-viral T cells increase prior to an episode of viral reactivation post human lung transplantation.
by: Thi H O Nguyen, et al.
Published: (2013-01-01) -
The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection.
by: Lucy C Sullivan, et al.
Published: (2015-01-01) -
The peripheral NK cell repertoire after kidney transplantation is modulated by different immunosuppressive drugs
by: Christine eNeudoerfl, et al.
Published: (2013-02-01) -
Lessons from practice Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia
by: Kong, DCM, et al. -
NK Cells of Kidney Transplant Recipients Display an Activated Phenotype that Is Influenced by Immunosuppression and Pathological Staging.
by: Ulrike Hoffmann, et al.
Published: (2015-01-01)